FlexAbility and FlexAbility Sensor Enabled
ABBOTT MEDICAL · Decision date Jan 15, 2026
What did the FDA decide?
FDA records P110016/S092 as a supplement to PMA P110016, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jan 15, 2026.
FDA approval order statement
an alternate vapor degreaser which is used as a processing aid to remove metalworking cutting fluid on patient-contacting tip electrodes and electrode rings during manufacturing
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Jan 15, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P110016/S092
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- OAD
- Decision code
- OK30
- Decision date
- Jan 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter.
- Applicant
- Abbott Medical
- Product code
- OAD
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P110016/S089 · Related supplement
FlexAbility Ablation Catheter, Sensor Enabled
P110016/S092 received
Application receipt date recorded by FDA.
P110016/S091 · Related supplement
FlexAbility Ablation Catheter (Flex) and FlexAbility Ablation Catheter, Sensor Enabled (Flex SE)
P110016/S092 · FDA decision
30-Day Notice
P110016/S093 · Related supplement
FlexAbility Ablation Catheter (Flex) and FlexAbility Ablation Catheter, Sensor Enabled (Flex SE)
P110016/S094 · Related supplement
FlexAbility Ablation Catheter; FlexAbilityTM Ablation Catheter, Sensor EnabledTM
P110016/S095 · Related supplement
Ampere Generator
Timeline entries are records held by MedtechLedger for P110016. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P110016
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FlexAbility Ablation Catheter, Sensor EnabledP110016/S089 | ABBOTT MEDICAL | PMA supplement | Oct 16, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Jan 8, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Apr 9, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Jun 5, 2026 | FDA | |
Ampere GeneratorP110016/S095 | ABBOTT MEDICAL | PMA supplement | Aug 7, 2026 | FDA |
Explore the linked device profile
Other records with product code OAD
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
Therapy Dual-8 Ablation CatheterP040042/S060 | Irvine Biomedical,Inc.(Ibi) | PMA supplement | Sep 3, 2026 | FDA |
THERMOCOOL SMARTTOUCH SF CatheterP030031/S142 | Biosense Webster, Inc. | PMA supplement | Sep 2, 2026 | FDA |
Ampere GeneratorP040042/S059 | Irvine Biomedical,Inc.(Ibi) | PMA supplement | Aug 7, 2026 | FDA |
Ampere GeneratorP060019/S059 | Irvine Biomedical, Inc. | PMA supplement | Aug 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 2375 Morse Ave., Plymouth, MN, 55442
Sources and methodology
- Original FDA record: P110016/S092
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


